Offer price of Baltic Horizon Fund unit in the secondary

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Offer price of Baltic Horizon Fund unit in the secondary public offering

Northern Horizon Capital AS as management company of Baltic Horizon Fund announced on 8 November to Nasdaq Tallinn of registration of prospectus for public offering and listing of up to 31,131,000 new units of Baltic Horizon Fund.  The number of new Fund units may increase further by 22,279,000, i.e. up to 59,410,000 (the Offer Units) in case the Management Company decides to use the Upsizing Option.

Pursuant to the terms of the prospectus the price for Offer Units is equal to the NAV of the Unit of the Fund as at 31 October 2016 and will not exceed EUR 1.37 per Offer Unit. Net asset value of Baltic Horizon Fund unit as of 31 October 2016 is EUR 1.3456 per unit. Therefore price for Offer Unit is EUR 1.3456 per unit. The price for Offer Units is the same for institutional investors and retail investors.

Baltic Horizon Fund is a registered public closed-end real estate fund and Baltic Horizon units began trading on the Nasdaq Baltic Fund list of July 6, 2016. The company's stock symbol (ticker) is NHCBHFFT.

The fund is managed by Northern Horizon Capital AS under an Alternative Investment Fund Manager license granted by the Estonian Financial Supervision Authority.

Additional information:

Tarmo Karotam Baltic Horizon Fund manager E-mail  tarmo.karotam@nh-cap.com www.baltichorizon.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading